Turkish Validity and Reliability of the Bolus Residue Scale in Acute Stroke (NCT07435441) | Clinical Trial Compass
CompletedNot Applicable
Turkish Validity and Reliability of the Bolus Residue Scale in Acute Stroke
Turkey (Türkiye)40 participantsStarted 2025-08-01
Plain-language summary
This study aims to evaluate the validity and reliability of the Turkish version of the Bolus Residue Scale (BRS) in patients with acute stroke. The study has a methodological, observational, and cross-sectional design. Videofluoroscopic swallowing study (VFSS) recordings will be scored independently by trained raters using the BRS. Psychometric properties including construct validity, criterion validity, inter-rater and intra-rater reliability will be analyzed.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Diagnosis of acute stroke confirmed by neurological and radiological evaluation
* Age 18 years and older
* Undergoing videofluoroscopic swallowing study (VFSS) as part of routine clinical assessment
* Ability to participate in swallowing assessment procedures
* Provision of written informed consent by the patient or a legal representative
Exclusion Criteria:
* History of head and neck cancer or head and neck surgery
* Pre-existing neurological diseases affecting swallowing (e.g., Parkinson's disease, amyotrophic lateral sclerosis)
* Structural abnormalities of the upper aerodigestive tract
* Severe cognitive impairment preventing cooperation with assessment procedures
* Incomplete or poor-quality VFSS recordings unsuitable for analysis
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Bolus Residue Scale (BRS)
Timeframe: Baseline (during videofluoroscopic swallowing study assessment)